Investigation of Efficacy and Safety of Ragweed MATAMPL, Pollinex-R and Placebo in Patients With Ragweed Allergy

NCT00110786 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Type I Hypersensitivity

Interventions

BIOLOGICAL: Ragweed MATAMPL

Sponsor

Allergy Therapeutics